Cardiovascular risk factors in non-alcoholic fatty liver disease

被引:78
作者
Hagstrom, Hannes [1 ,2 ]
Nasr, Patrik [3 ,4 ]
Ekstedt, Mattias [3 ,4 ]
Hammar, Ulf [5 ]
Stal, Per [1 ,6 ]
Askling, Johan [2 ]
Hultcrantz, Rolf [1 ,6 ]
Kechagias, Stergios [3 ,4 ]
机构
[1] Karolinska Univ Hosp, Dept Upper GI, Div Hepatol, Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden
[3] Linkoping Univ, Dept Gastroenterol & Hepatol, Linkoping, Sweden
[4] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
[5] Karolinska Inst, Inst Environm Med, Biostat Unit, Stockholm, Sweden
[6] Karolinska Inst, Dept Med, Stockholm, Sweden
关键词
cardiovascular disease; epidemiology; fatty liver; hepatic fibrosis; non-alcoholic steatohepatitis; FIBROSIS STAGE; ATHEROSCLEROSIS; DYSFUNCTION; PROGRESSION; POPULATION; PREDICTOR; MORTALITY; EVENTS; NAFLD;
D O I
10.1111/liv.13973
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims Patients with non-alcoholic fatty liver disease (NAFLD) are at an increased risk for cardiovascular disease (CVD). It is unclear whether histological variables may help predict CVD risk. We evaluated histology and traditional CV risk factors as predictors of CVD outcomes in a large NAFLD cohort. Methods We included 603 biopsy-proven NAFLD patients free of baseline CVD and matched these (1:10, by age, sex and municipality) to 6269 population controls. All individuals were cross-linked to national registries to ascertain incident CVD events, defined as acute ischaemic heart disease or stroke. The presence of CV risk factors and liver histology were available in NAFLD patients only. Cox regression models were used to estimate hazard ratios (HR) for incident CVD. Results During a mean follow-up of 18.6 years, 168 (28%) of NAFLD patients and 1325 (21%) of controls experienced a CVD event (HR 1.54, 95%CI 1.30-1.83). Within the NAFLD cohort, age, male sex, type 2 diabetes, smoking and triglycerides were associated with risk of CVD. Taking these CV risk factors into account, no histological parameter, including presence of NASH and fibrosis stage, were associated with incident CVD. Conclusions Patients with NAFLD are at an increased risk for CVD compared to matched controls, but histological parameters do not seem to independently predict this risk.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 27 条
[1]   Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events [J].
Abd El Azeem, Hamdy ;
Khalek, El-Shazly Abdul ;
El-Akabawy, Hazem ;
Naeim, Hussein ;
Khalik, Hammouda Abdul ;
Alfifi, Abdul Aziz .
JOURNAL OF THE SAUDI HEART ASSOCIATION, 2013, 25 (04) :239-246
[2]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[3]   Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease [J].
Bedossa, Pierre .
HEPATOLOGY, 2014, 60 (02) :565-575
[4]   Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes [J].
Boddi, Maria ;
Tarquini, Roberto ;
Chiostri, Marco ;
Marra, Fabio ;
Valente, Serafina ;
Giglioli, Cristina ;
Gensini, Gian F. ;
Abbate, Rosanna .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (05) :429-438
[5]   Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes [J].
Bonapace, Stefano ;
Perseghin, Gianluca ;
Molon, Giulio ;
Canali, Guido ;
Bertolini, Lorenzo ;
Zoppini, Giacomo ;
Barbieri, Enrico ;
Targher, Giovanni .
DIABETES CARE, 2012, 35 (02) :389-395
[6]   The Swedish cause of death register [J].
Brooke, Hannah Louise ;
Talback, Mats ;
Hornblad, Jesper ;
Johansson, Lars Age ;
Ludvigsson, Jonas Filip ;
Druid, Henrik ;
Feychting, Maria ;
Ljung, Rickard .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2017, 32 (09) :765-773
[7]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873
[8]   Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up [J].
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Fredrikson, Mats ;
Stal, Per ;
Kechagias, Stergios ;
Hultcrantz, Rolf .
HEPATOLOGY, 2015, 61 (05) :1547-1554
[9]   Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up [J].
Fracanzani, Anna Ludovica ;
Tiraboschi, Silvia ;
Pisano, Giuseppina ;
Consonni, Dario ;
Baragetti, Andrea ;
Bertelli, Cristina ;
Norata, Danilo ;
Valenti, Luca ;
Grigore, Liliana ;
Porzio, Marianna ;
Catapano, Alberico ;
Fargion, Silvia .
ATHEROSCLEROSIS, 2016, 246 :208-213
[10]   Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD [J].
Hagstrom, Hannes ;
Nasr, Patrik ;
Ekstedt, Mattias ;
Hammar, Ulf ;
Stal, Per ;
Hultcrantz, Rolf ;
Kechagias, Stergios .
JOURNAL OF HEPATOLOGY, 2017, 67 (06) :1265-1273